HypercholesterolemiaHyperlipoproteinemia Type IICholesterolAnticholesteremic AgentsReceptors, LDLCholesterol, LDLCholesterol, DietaryLipoproteins, LDLHydroxymethylglutaryl-CoA Reductase InhibitorsXanthomatosisApolipoproteins BEpichlorohydrinAzetidinesLipidsDiet, AtherogenicLipoproteinsTriglyceridesSimvastatinApolipoproteins EHeterozygoteHomozygoteLovastatinCholesterol, HDLHeptanoic AcidsHyperlipidemiasBlood Component RemovalProprotein ConvertasesPravastatinProbucolRisk FactorsRabbitsPyrrolesAnion Exchange ResinsResins, SyntheticEndothelium, VascularPsylliumAortaApolipoprotein B-100Hypolipidemic AgentsCholestyramine ResinHypertriglyceridemiaPedigreeLiverLipoproteins, IDLDisease Models, AnimalLipoproteins, VLDLFluorobenzenesHypertensionColestipolVasa VasorumArcus SenilisHydroxymethylglutaryl CoA ReductasesVasodilationCoronary DiseaseLipoprotein-XApolipoproteinsSitosterolsPhytosterolsLipoproteins, HDLDietary FatsCholesterol 7-alpha-HydroxylaseHyperlipidemia, Familial CombinedLipid MetabolismCrataegusMice, Inbred C57BLMice, KnockoutSwineCholesterol, VLDLCoronary Artery DiseaseMutationJapanCoronary VesselsPortugalLipoprotein(a)Swine, MiniatureTime FactorsNitroprussideTyphaceaeNitric OxidePhenotypeVasodilator AgentsDyslipidemiasDouble-Blind MethodDiabetes MellitusBile Acids and SaltsSerine EndopeptidasesTunica IntimaMevalonic AcidReceptors, LipoproteinDietFatty Acids, MonounsaturatedBody WeightSterolsAcetylcholinePrevalenceHyperlipoproteinemiasOxidative StressHeredityApolipoprotein A-ITreatment Outcome